Hippocratic AI, the company pioneering the first safety-focused Large Language Model (LLM) for healthcare, has announced the issuance of its first patent, US Patent 12,142,371, granted by the US Patent…
Aulos Bioscience, an innovative immuno-oncology company focused on developing potentially groundbreaking IL-2 therapeutics to revolutionize cancer care, has announced the dosing of its first patient in a Phase 2 clinical…
Median Technologies (FR0011049824, ALMDT), a leading innovator in the development of artificial intelligence (AI)-powered medical devices for early cancer detection, is set to attend the Radiological Society of North America…
Trustwise, an AI performance and risk management innovator, has partnered with Health Innovation Kent Surrey Sussex (Health Innovation KSS), Hitachi Digital Services, and Further to co-develop MedAssist GPT, a generative…
Anteris Technologies Global Corp. (“ATGC”) announced today that it has filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for the proposed initial public…
CVS Health has made history as the first healthcare company to earn accreditation for Health Equity from URAC, a distinction granted for the impactful work carried out through CVS Caremark…
OverT Bio, a cell therapy company based in New York City, has announced it has received a $120,000 G-Rex Grant from ScaleReady™, in partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation…
Greenspace Health, a leading provider of Measurement-Based Care (MBC) technology for behavioral health services, has been named to the 2024 Deloitte Technology Fast 500™. This prestigious ranking highlights the 500…
Nym, a leader in autonomous medical coding, has been recognized in The Healthcare Technology Report’s list of Top 100 Healthcare Technology Companies for 2024. This accolade highlights Nym’s significant contribution…
After nearly 30 years as a leader in lab quality management, MediaLab has announced its rebrand to Vastian. This change reflects the company’s growth and expansion to address the broader…
While every company wants to support their employees’ health, businesses of all sizes face challenges with rising healthcare costs and complex, confusing benefit plans. Prescription medications can be a tough…
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading biotechnology company focused on developing genetic therapies for rare, life-threatening diseases, announced promising long-term safety and efficacy data from its Phase 1 RP-A501…